Neurodegenerative diseases (NDs) pose clinical challenges due to their complexity and molecular heterogeneity. Here, we present a pan-neurodegeneration atlas (PanNDA) from multilayer, deep proteomic analysis of 2,279 human brain samples spanning 6 major NDs: Alzheimer's disease (AD), Lewy body dementia (LBD), frontotemporal lobar degeneration with TDP-43 pathology, progressive supranuclear palsy with tau pathology, vascular dementia, and Parkinson's disease. PanNDA integrates data from whole pro
Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures
Him K. Shrestha·Junmin Peng·David Vanderwall·Yu Sun·Danting Liu·Michael DeTure·Erming Wang·GE Serrano·H. J. Wang·Masihuz Zaman·Dehui Kong·GuoJun Bu·Bing Bai·Júlia Faura·Yong Li·Meghan McReynolds·Shu Yang·Mingming Niu·Suresh Poudel·Chunyu Liu·Boer Xie·Xusheng Wang·Kaiwen Yu·Zuo-Fei Yuan·Ju Wang·Zhiping Wu·Rosa Rademakers·Ping-Chung Chen·Vahram Haroutunian·Nan Zhang·Zhen Wang·Dennis W. Dickson·Jay M. Yarbro·Ronald C. Petersen·Allan I. Levey·Minghui Wang·Huan Sun·Erik C.B. Johnson·Takahisa Kanekiyo·Nicholas T. Seyfried·Thomas G. Beach·David A. Bennett·DongGeun Lee·Gang Yu·Pamela J. McLean·Bin Zhang·Anthony A. High

